# SKYRIZI
> **BLA761262** · Biologics License Application · Sponsor: ABBVIE INC · Approved 2022-06-16
## Drug
- **FDA Application Number:** BLA761262
- **Application type:** Biologics License Application
- **Brand name:** SKYRIZI
- **Generic name:** RISANKIZUMAB-RZAA
- **Active ingredients:** RISANKIZUMAB-RZAA
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE INC
- **Manufacturer:** AbbVie Inc.
- **First approval:** 2022-06-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761262)
---
*AI Analytics · CC0 1.0*